About this trial
Peripheral neuropathy is a frequent condition, commonly associated with pain. Repetitive Transcranial Magnetic Stimulation (rTMS) is a noninvasive method of modulation of brain plasticity and is regarded as one of alternative methods to alleviate pain associated with various kind of neuropathies. rTMS is usually performed once a day and the whole therapy of neuropathic pain lasts one week. In a number of recent clinical trials including patients with depression and some other disorders, rTMS was delivered several times a day, which reduced the time of the whole therapy. This approach was termed an accelerated rTMS. The purpose of this study is to investigate feasibility of accelerated rTMS in treatment of neuropathic pain.
Eligibility criteria
Qualifiers
Diagnosis of peripheral neuropathy
Neuropathic pain of constant severity since not less than a month and requiring use of analgesics more than once a week
Score of 30 millimeter or more on the 100 millimeter visual analog scale of pain intensity at inclusion
Disqualifiers
Severe depression
Personality disorders and other psychiatric conditions, which could disturb the participation in the study
Cognitive deficits, which could disturb the participation in the study
Epilepsy
Trial design
Treatments tested in this trial
- Active repetitive transcranial magnetic stimulation
- Sham repetitive transcranial magnetic stimulation
Treatment groups
Sponsors and collaborators
Jakub Antczak
Lead sponsor
Jagiellonian University
Sponsor institution